missing translation for 'onlineSavingsMsg'
Learn More

beta Amyloid (1-40) Rabbit anti-Human, Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Brand:  Invitrogen 44348A

Code : 50

Additional Details : Weight : 0.50000kg

Product Code. 10553185

  • £330.00 / Each

Estimated Shipment: 10-08-2021

Please to purchase this item. Need a web account? Register with us today!


For Research Use Only. All usage must comply with product instructions.
 

Description

Description

This antibody reacts with human beta Amyloid (1-40). No significant cross-reactivity to beta Amyloid (1-42) has been observed. Previous lots have shown no cross-reactivity against beta Amyloid (1-43). The antibody has been used in ELISA. Previous lots of this antibody have been used in dot blots, RIA, and other related assays.

Amyloid beta peptide (Abeta/Beta-amyloid) is the major constituent of amyloid plaques in the brains of individuals afflicted with Alzheimer′s disease. Abeta peptide is 40-43 amino acids long and generated from the beta-amyloid precursor protein (beta APP) in a two-step process. The first step involves cleavage of the extracellular, amino-terminal domain of beta APP. Protein cleavage is performed by an aspartyl protease, beta-secretase (BACE) which is synthesized as a propeptide and must be modified to the mature and active form by the prohormone convertase, furin. Beta APP cleavage by the mature form of BACE results in the cellular secretion of a segment of beta APP, and a membrane-bound remt. The remt protein is processed by another protease, gamma-secretase. Gamma-secretase cleaves an intra-membrane site in the carboxyl-terminal domain of beta APP, thus generating the amyloid beta peptide. Gamma-secretase is believed to be a multi-subunit complex containing presenilin-1 and 2 as central components. The transmembrane glycoprotein, nicastrin, is associated with presinilins and has been found to bind to the carboxyl-terminus of beta APP and helps to modulate the production of the amyloid beta peptide. Abeta is an extracellular filamentous protein component of amyloid cores, neuritic plaques and is also found as a deposit in neurofibrillary tangles. Alzheimer’s disease, the most common cause of senile dementia, is characterized by abnormal filamentous protein deposits in the brain. Beta amyloid deposits are also detected in Lewy body dementia, Down’s syndrome, amyloidosis (Dutch type), cerebroarterial amyloidosis (cerebral amyloid angiopathy) and in the Guam Parkinson-Dementia complex.
Specifications

Specifications

beta Amyloid (1-40)
Polyclonal
Unconjugated
APP
Liquid
APP
The antibody was produced using a synthetic peptide derived from amino acids 34-40 within the C-terminal region of human beta-Amyloid protein.
Antigen affinity chromatography
RUO
Antibody
Polyclonal
Human
Dot Blot, ELISA, Radioimmune Assays
1 mg/mL
Dulbecco′s PBS with no preservative; pH 7.3
P05067
AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN2, Alzheimer disease amyloid A4 protein homolog, APP, Amyloidogenic glycoprotein AG, Amyloid beta A4 protein, amyloid beta (A4) precursor protein, Peptidase nexin-II
Rabbit
IgG
25 μg
-20°C
Primary
351
Videos
SDS
Documents
Certificates